Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2007 1
2011 1
2012 5
2013 2
2014 5
2015 8
2016 18
2017 14
2018 13
2019 12
2020 8
2021 9
2022 17
2023 10

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Results by year

Filters applied: . Clear all
Page 1
Nanobodies as novel therapeutic agents in envenomation.
Alirahimi E, Kazemi-Lomedasht F, Shahbazzadeh D, Habibi-Anbouhi M, Hosseininejad Chafi M, Sotoudeh N, Ghaderi H, Muyldermans S, Behdani M. Alirahimi E, et al. Among authors: behdani m. Biochim Biophys Acta Gen Subj. 2018 Dec;1862(12):2955-2965. doi: 10.1016/j.bbagen.2018.08.019. Epub 2018 Aug 30. Biochim Biophys Acta Gen Subj. 2018. PMID: 30309831 Review.
Efficacy and antitumor activity of a mutant type of interleukin 2.
Dehghan R, Beig Parikhani A, Zeinali S, Shokrgozar M, Amanzadeh A, Ajdary S, Ahangari Cohan R, Talebkhan Y, Behdani M. Dehghan R, et al. Among authors: behdani m. Sci Rep. 2022 Mar 30;12(1):5376. doi: 10.1038/s41598-022-09278-7. Sci Rep. 2022. PMID: 35354847 Free PMC article.
A nanobody-derived mimotope against VEGF inhibits cancer angiogenesis.
Karami E, Sabatier JM, Behdani M, Irani S, Kazemi-Lomedasht F. Karami E, et al. Among authors: behdani m. J Enzyme Inhib Med Chem. 2020 Dec;35(1):1233-1239. doi: 10.1080/14756366.2020.1758690. J Enzyme Inhib Med Chem. 2020. PMID: 32441172 Free PMC article.
In vivo solid tumor targeting with recombinant VEGF-diphtheria immunotoxin.
Hosseininejad-Chafi M, Alirahimi E, Ramezani B, Oghalaie A, Sotoudeh N, Ghaderi H, Kazemi-Lomedasht F, Habibi-Anbouhi M, Moazzami R, Behdani M. Hosseininejad-Chafi M, et al. Among authors: behdani m. Iran J Basic Med Sci. 2022 Jan;25(1):27-31. doi: 10.22038/IJBMS.2021.54293.12195. Iran J Basic Med Sci. 2022. PMID: 35656448 Free PMC article.
105 results